Helping Patients Take Their Next Breath
VentFree™ Respiratory Muscle Stimulator
Power to Liberate – Preparing to Wean from Day One of Mechanical Ventilation.
The VentFree respiratory muscle stimulator activates the abdominal muscles in mechanically ventilated patients using proprietary non-invasive electrical stimulation applied during exhalation. As electrical stimulation does not require patient participation, therapy can begin from day one of mechanical ventilation while patients are sedated or delirious. This breakthrough approach, which is quick and simple to use, is intended to prevent abdominal muscle atrophy and reduce the time taken to liberate patients from mechanical ventilation.
Addressing an Unmet Clinical Need
Expiratory muscle atrophy is often found in mechanically ventilated patients and can result in insufficient cough, inadequate secretion clearance and reduced neuromuscular efficiency of the diaphragm. In addition, reduced expiratory muscle strength is associated with weaning failure and delayed extubation.
Patients who require more than four days of mechanical ventilation suffer from high rates of hospital mortality, morbidity and post-discharge complications.
Improving Clinical Outcomes
A pilot randomized controlled trial, which included 20 critically-ill, mechanically ventilated patients, found that mechanical ventilation duration and ICU length of stay were shorter in patients who received stimulation with the VentFree respiratory muscle stimulator compared to those who received placebo stimulation.
Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life and significant savings for the health care provider
The VentFree respiratory muscle stimulator is CE marked and is available for sale within the European Economic Area (EEA). Outside of the EEA, the VentFree respiratory muscle stimulator is an investigational device only and is not for sale.
For more information, please contact us.
Adverse Event Reporting
To report an adverse event, please call: 1-800-683-5526
Join our Mailing List
Liberate Medical is keen to keep you updated on our developments and the easiest way to do that is if we can email you when things happen.
We develop medical devices to improve the quality of life and reduce the cost of care for patients with pulmonary indications.
Angus J. McLachlan, PhD
Co-Founder and Chief Executive Officer
Dr. McLachlan co-founded Liberate Medical and has served as a member of its board of directors and its Chief Executive Officer since 2013. From 2014 to 2016, he also served as the Director for Device Integration and Strategy for Revon Systems. Dr. McLachlan completed his doctoral research on Liberate Medical’s proprietary electrical muscle stimulation technology and was responsible for the initial product development of VentFree and SecondBreath, which led to the technology being spun out of Apellis Pharmaceuticals. He is co-inventor on all of Liberate Medical’s patents and has authored several important publications in the field of abdominal functional electrical stimulation. Dr. McLachlan received his M.Eng. in Mechanical Engineering and his Ph.D. in Biomedical Engineering from the University of Glasgow, Scotland.
Guillermo J. Cohen Freue, MS
Vice President of Engineering
Guillermo J. Cohen Freue initially joined Liberate Medical as a consultant and has served as Vice President of Engineering since 2016. Prior to joining Liberate Medical he served as Director of Research and Development of Angelini Pharma Inc. Guillermo, a co-founder of several medical device companies, has designed and developed a wide range of devices and led the groups that obtained market clearance through the FDA approval process of the mentioned systems. Throughout his 20+ years of tenure, Guillermo has also developed technical training programs and medical devices software products. Guillermo received his M.S. in Electrical Engineering from the Universidad de Buenos Aires, Argentina.
Cedric Francois, MD / PhD
Co-Founder and Director
Cedric Francois’ primary areas of expertise are immunology and immune system mediated disease. Cedric Francois received his medical degree from the University of Leuven in Belgium and his Ph.D. in Physiology from the University of Louisville. Following postgraduate training in pediatric and transplant surgery, Dr. Francois was a member of the research team that performed the first successful hand transplantation and of the Louisville Face Transplant Team, whose work supported the first human face transplantation in Lyon, France in 2005.
A fourth generation business owner, John was born an entrepreneur. His passion is analyzing, strategizing, and capitalizing businesses. John has personal experience with start-ups, family owned businesses, generational businesses, and businesses in crisis situations.
John adds an optimistic approach to life as well as business. He excels at discovering opportunities, defining key metrics and implementing sales and marketing strategies.
Rod Wolford has over 40 years of wide-ranging experience in the health care industry, having served in leadership roles with health care providers, suppliers, consulting firms, associations and insurers.
Redirecting his professional time from active executive leadership, he now focuses his time on multiple boards of directors, his farm in Kentucky, community economic development and three growing grandchildren.